Studying lung immune cells and gut microbes in ARDS
Part of Lungs & breathing clinical trials.
This trial studies how immune cells in the lungs and gut microbes (your microbiome) change during ARDS and how these changes relate to your outcomes. It may help researchers better predict and treat ARDS by learning what’s going on in the lungs and body systems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently admitted to the ICU at Hvidovre Hospital
- You were intubated (breathing tube placed) within the last 72 hours
- You have ARDS that is moderate-to-severe or none-to-mild based on a standard definition
- Your ARDS is not caused by COVID-19
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the risk of lung injury in patients on a ventilator who have ARDS (a severe lung inflammation). It aims to better understand how the lungs respond and to find safer breathing settings for you.
This study looks at how immune cells in the lungs relate to the microbiome (the helpful microbes in the gut) in healthy adults. It may help scientists understand what affects lung health and immune balance.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This study looks at how the immune system responds in people with ARDS (a severe lung injury) and tests a new treatment called PIP-2 in the lab to see if it might help. It aims to better understand lung injury and find new ways to treat it.
This study looks at a specific breathing event (“avalanche phenomenon”) when the lungs are opened in people with early, moderate-to-severe ARDS. The goal is to understand what’s happening in the lungs and whether it can guide better care.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
Hear when a new ARDS, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.